Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in Natalizumab Population With Active Control
N/A
The purpose of the study is to research the association between receiving T...
Status
Completed
Location
Rocky Mountain MS Clinic
Start Date
2012-07
Trial ID
NCT01626248
A Study to Describe the Switching From a First- or Second-line Disease Modifying Therapy (DMT) to Ozanimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)
N/A
The purpose of this study is to describe the reasons, therapy, and/or disea...
Status
Completed
Location
Local Institution - 0001
Start Date
2023-07-14
Trial ID
NCT05658601
Safety and Pharmacokinetics of GH002 in Healthy Volunteers
PHASE1
The primary objectives of this study are to investigate the safety and seru...